UNIGE document Scientific Article
previous document  unige:83859  next document
add to browser collection
Title

In silico driven design and synthesis of rhodanine derivatives as novel antibacterials targeting the enoyl reductase InhA

Authors
Kranjc-Pietrucci, Agata
Patthey-Vuadens, Ophélie
Ouertatani-Sakouhi, Hajer
show hidden authors show all authors [1 - 16]
Published in Journal of Medicinal Chemistry. 2016, vol. 59, no. 24, p. 10917–10928
Abstract Here, we report on the design, synthesis and biological evaluation of 4-thiazolidinone (rhodanine) de-rivatives targeting Mycobacterial tuberculosis (Mtb) trans-2-enoyl-acyl carrier protein reductase (InhA). Compounds having bulky aromatic substituents at position 5 and a tryptophan residue at position N-3 of the rhodanine ring were the most active against InhA with IC50 values ranging from 2.7 µM to 30 µM. The experimental data showed consistent correlations with computational studies. Their anti-microbial activity was assessed against Mycobacterium marinum (Mm) (a model for Mtb), Pseudomonas aeruginosa (Pa), Legionella pneumophila (Lp) and Enterococcus faecalis (Ef), by using anti-infective, anti-virulence and antibiotic assays. 19 out of 34 compounds reduced Mm virulence at 10 µM. 33 exhibited promising antibiotic activity against Mm with a MIC of 0.21 µM and showed up to 89% reduction of Lp growth in an anti-infective assay at 30 µM. 32 showed high antibiotic activity against Ef with a MIC of 0.57 µM.
Identifiers
PMID: 26730986
Full text
Article (Published version) (1.3 MB) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Phagocytose (140)
Citation
(ISO format)
SLEPIKAS, Liudas et al. In silico driven design and synthesis of rhodanine derivatives as novel antibacterials targeting the enoyl reductase InhA. In: Journal of Medicinal Chemistry, 2016, vol. 59, n° 24, p. 10917–10928. https://archive-ouverte.unige.ch/unige:83859

175 hits

4 downloads

Update

Deposited on : 2016-05-25

Export document
Format :
Citation style :